Brief: Lee's Pharmaceutical Holdings - QTRLY Revenue HK$283.7 Mln Versus HK$324.6 Mln
Aug 27 (Reuters) - Lee's Pharmaceutical Holdings Ltd
0950.HK :
* QTRLY REVENUE HK$283.7 MILLION VERSUS HK$324.6 MILLION
* QTRLY PROFIT ATTRIBUTABLE HK$57.1 MILLION VERSUS LOSS OF
HK$8.7
MILLION
* RECOMMENDED AN INTERIM DIVIDEND OF HK$0.027 PER SHARE
* GROUP FORESEES TOUGH ENVIRONMENT WILL BE PERSISTED
THROUGHOUT
THIS YEAR
Source text for Eikon: urn:newsml:reuters.com:*:nHKS7FcQ68
Further company coverage: 0950.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lees Pharmaceutical Holdings
See all newsBrief: Lee's Pharmaceutical Announces Share Repurchase Program Under Repurchase Mandate
Brief: Lee's Pharmaceutical To Receive Funding From Gates Foundation For Synthetic Surfactant Project
Brief: Lee's Pharmaceutical Says Zhaoke Hefei To Contribute Rmb25 Million To Partnership Fund
Brief: Lee's Pharmaceutical Declares Final Dividend Of HK2.3 Cents Per Share
Brief: Lee's Pharmaceutical Reports Approval Of Intrarosa By NMPA